Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 30, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-41755

WK Kellogg Co

State or other jurisdiction of incorporation or organization—

Delaware

IRS Employer Identification No.

92-1243173

Address of principal executive offices: One Kellogg Square, Battle Creek, MI Zip Code: 49016-3599

Registrant’s telephone number, including area code: 269-401-3000

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $.0001 par value per share	KLG	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

As of May 1, 2024 — 85,877,528 shares of the registrant's common stock were outstanding

Table of Contents

WK KELLOGG CO

INDEX


			Page
PART I — Financial Information
Item 1:
Financial Statements
Unaudited Consolidated Balance Sheet — March 30, 2024 and December 30, 2023			3
Unaudited Consolidated Statement of Income — quarters ended March 30, 2024 and April 1, 2023			4
Unaudited Consolidated Statement of Comprehensive Income – quarters ended March 30, 2024 and April 1, 2023			5
Unaudited Consolidated Statement of Equity — quarters ended March 30, 2024 and April 1, 2023			6
Unaudited Consolidated Statement of Cash Flows — quarters ended March 30, 2024 and April 1, 2023			7
Notes to Unaudited Consolidated Financial Statements			8
Item 2:
Management’s Discussion and Analysis of Financial Condition and Results of Operations			15
Item 3:
Quantitative and Qualitative Disclosures about Market Risk			22
Item 4:
Controls and Procedures			22
PART II — Other Information
Item 1A:
Risk Factors			23


Item 5 :
Other Information			23
Item 6:
Exhibits			24
Signatures			25

Table of Contents

Part I – FINANCIAL INFORMATION

Item 1. Financial Statements.

WK KELLOGG CO

CONSOLIDATED BALANCE SHEET (Unaudited)

(millions, except per share data)


	March 30, 2024		December 30, 2023
Current assets
Cash and cash equivalents	$	70	$	89
Accounts receivable, net	244		244
Inventories	328		345
Other current assets	22		28
Total current assets	664		706
Property, net	735		739

Goodwill	53		53
Other intangibles	57		57
Postretirement plan assets	292		283
Other assets	87		51
Total assets	$	1,888	$	1,889
Current liabilities
Notes payable	$	2	$	4
Current maturities of long-term debt	8		8
Accounts payable	544		541
Accrued advertising and promotion	109		121
Accrued salaries and wages	36		57
Other current liabilities	90		105
Total current liabilities	789		836
Long-term debt	484		487
Deferred income taxes	107		106
Pension liability	133		135

Other liabilities	58		25
Commitments and contingencies (Note 9)
Equity
Common stock, $0.0001 par value, 1,000,000,000 shares authorized Issued: 85,808,508 shares in 2024 and 85,812,883 shares in 2023	—		—
Capital in excess of par value	329		327
Retained earnings	20		1

Accumulated other comprehensive loss	(32)		(28)


Total equity	317		300
Total liabilities and equity	$	1,888	$	1,889

See accompanying Notes to Unaudited Consolidated Financial Statements.

Table of Contents

WK KELLOGG CO

CONSOLIDATED STATEMENT OF INCOME (Unaudited)

(millions, except per share data)


	Quarter ended
	March 30, 2024		April 1, 2023
Net sales	$	707	$	720
Cost of goods sold	504		540
Selling, general and administrative expense	157		156
Operating profit	46		24
Interest expense	8		—
Other income (expense), net	6		8
Income before income taxes	44		32
Income taxes	11		8
Net income	$	33	$	24


Per share amounts (a):
Basic earnings	$	0.38	$	0.28
Diluted earnings	0.37		0.28

Average shares outstanding:
Basic	86		86
Diluted	87		86
Actual shares outstanding at period end	86		86

(a)On October 2, 2023, Kellanova, the former parent company of WK Kellogg Co, distributed 85,631,304 shares of WK Kellogg Co common stock to Kellanova's shareowners in connection with its Spin-Off of WK Kellogg Co (the "Spin-Off"). See Note 1 "Accounting Policies" to the Unaudited Consolidated Financial Statements for more information. Basic and diluted earnings per share were retrospectively recast for the number of shares of WK Kellogg Co common stock outstanding immediately following the Spin-Off for the quarter ended April 1, 2023.

See accompanying Notes to Unaudited Consolidated Financial Statements.

Table of Contents

WK KELLOGG CO

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited)

(millions)


	Quarter ended
	March 30, 2024
	Pre-tax amount		Tax (expense) benefit		After-tax amount
Net income	$	44	$	(11)	$	33
Other comprehensive income (loss):
Foreign currency translation adjustments:
Foreign currency translation adjustments during period	(3)		1		(2)





Postretirement and postemployment benefits:


Reclassification to net income:

Prior service cost	(1)		—		(1)




Comprehensive income	$	40	$	(10)	$	30




	Quarter ended
	April 1, 2023
	Pre-tax amount		Tax (expense) benefit		After-tax amount
Net income	$	32	$	(8)	$	24
Other comprehensive income (loss):
Foreign currency translation adjustments:
Foreign currency translation adjustments during period	2		—		2















Comprehensive income	$	34	$	(8)	$	26

See accompanying Notes to Unaudited Consolidated Financial Statements.

Table of Contents

WK KELLOGG CO

CONSOLIDATED STATEMENT OF EQUITY (Unaudited)

(millions)


	Quarter ended March 30, 2024
	Common stock			Capital in excess of par value		Retained earnings		Accumulated other comprehensive income (loss)			Total equity
(unaudited)	shares	amount
Balance, December 30, 2023	86	$	—	$	327	$	1		$	(28)		$	300

Net income	—	—		—		33			—			33


Dividends declared ($0.16 per share)	—	—		—		(14)			—			(14)

Other comprehensive income (loss)	—	—		—		—			(4)			(4)
Stock compensation	—	—		1		—			—			1

Share issuance	—	—		1		—			—			1

Balance, March 30, 2024	86	$	—	$	329	$	20		$	(32)		$	317


		Quarter ended April 1, 2023
	Net Kellanova investment	Capital in excess of par value		Retained earnings				Accumulated other comprehensive income (loss)			Total equity
(unaudited)
Balance, December 31, 2022		$	725	$	—	$	—		$	(38)		$	687

Net income		24		—		—			—			24
Net transfer (to)/from Kellanova		(36)		—		—			—			(36)


Other comprehensive income		—		—		—			2			2



Balance, April 1, 2023		$	713	$	—	$	—		$	(36)		$	677

See accompanying Notes to Unaudited Consolidated Financial Statements.

Table of Contents

WK KELLOGG CO

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

(millions)


	Year-to-date period ended
	March 30, 2024		April 1, 2023
Operating activities
Net income	$	33	$	24
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	19		17
Postretirement plan benefit	(9)		(7)
Deferred income taxes	1		—
Stock compensation	1		1


Other	3		—
Pension plan contributions	(3)		—
Changes in operating assets and liabilities:
Trade receivables	2		7
Inventories	16		57
Accounts payable	(5)		(23)
Income taxes payable	4		—
Accrued advertising and promotion	(11)		(2)
Accrued salaries and wages	(21)		(8)
All other current assets and liabilities	(20)		(4)
Net cash provided by (used in) operating activities	10		62
Investing activities
Additions to properties	(9)		(31)












Net cash provided by (used in) investing activities	(9)		(31)
Financing activities

Repayment of borrowings under the Credit Agreement	(3)		—


Issuance (repayment) of notes payables, with maturities less than 90 days	(3)		—

Net issuances of common stock	1		—

Dividends paid	(14)		—

Net transfers (to) from Kellanova	—		(30)
Net cash provided by (used in) financing activities	(19)		(30)
Effect of exchange rate changes on cash and cash equivalents	—		—
Increase (decrease) in cash and cash equivalents	(18)		1
Cash and cash equivalents at beginning of period	88		—
Cash and cash equivalents at end of period	$	70	$	1

Supplemental cash flow disclosures of non-cash investing activities:
Additions to properties included in accounts payable	$	20	$	27

See accompanying Notes to Unaudited Consolidated Financial Statements.

Table of Contents

Notes to Unaudited Consolidated Financial Statements

for the quarter ended March 30, 2024 (unaudited)

Note 1 Accounting policies

Basis of presentation

On October 2, 2023 ("Spin-Off Date"), Kellanova (formerly known as Kellogg Company) completed the spin-off (the "Spin-Off") of its North American cereal business, resulting in a new independent public company, WK Kellogg Co (the "Company"). Prior to the Spin-Off, the Company historically operated as part of Kellanova.

For periods prior to the Spin-Off, the accompanying Unaudited Financial Statements were derived from the consolidated financial statements and accounting records of Kellanova. For all periods subsequent to the Spin-Off, the Unaudited Consolidated Financial Statements are based on actual results as a standalone company. Further information surrounding the Spin-Off and basis of presentation utilized for periods prior to the Spin-Off is included within Note 1 of the Company’s 2023 Annual Report on Form 10-K (the "2023 Annual Report").

In connection with the Spin-Off, the Company entered into several agreements with Kellanova that govern the relationship of the parties following the Spin-Off and allocate between WK Kellogg Co and Kellanova various assets, liabilities, and obligations, including, among other things, employee benefits, intellectual property, and tax related assets and liabilities. The agreements included a Separation and Distribution Agreement, Employee Matters Agreement, Supply Agreement, Master Ownership and License Agreements regarding Patents, Trademarks and Certain Related Intellectual Property, Tax Matters Agreement and Transition Services Agreement.

The allocation of expenses from Kellanova to the Company was reflected as follows in the Unaudited Consolidated Statement of Operations for the quarter ended April 1, 2023:


	Quarter ended
(millions)	April 1, 2023
Cost of goods sold	$	55
Selling, general and administrative	85
Other (income) expense, net	(6)
Total	$	134

The components of net parent investment for the quarter ended April 1, 2023 are:


(millions)	April 1, 2023
Net transfers (to)/from Kellanova as reflected in the Unaudited Combined Statement of Cash Flow	$	(30)
Non-cash stock compensation expense	1
Non-cash pension and postretirement benefit	(7)
Net transfers from/(to) Kellanova as reflected in the Unaudited Combined Statement of Changes in Equity	$	(36)

These statements reflect the results of operations, financial position and cash flows of the Company prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The unaudited interim financial information of the Company included in this report reflects all adjustments, all of which are of a normal and recurring nature, that management believes are necessary for a fair statement of the results of operations, comprehensive income, financial position, equity and cash flows for the periods presented. This interim information should be read in conjunction with the financial statements and accompanying footnotes within the 2023 Annual Report.

The balance sheet information at December 30, 2023 was derived from audited financial statements, but does not include all disclosures required by GAAP in the United States. The results of operations for the quarter ended March 30, 2024 are not necessarily indicative of the results to be expected for other interim periods or the full year.

Table of Contents

During the second quarter of 2023, the Company identified certain immaterial errors in its unaudited historical Combined Financial Statements as of and for the three month period ended April 1, 2023, related primarily to certain information technology, inventory and operational costs recorded by Kellanova which should have been recorded in its previously issued Unaudited Combined Statement of Cash Flows for the three month period ended April 1, 2023. Although management has determined that such errors did not materially misstate such prior financial statements, the Company has revised certain amounts within the prior year comparable period shown on its Unaudited Consolidated Statement of Cash Flows to increase Net cash provided by (used in) financing activities by $6 million and decrease Net cash provided by (used in) operating activities by $5 million resulting in a net Increase (decrease) in cash and cash equivalents associated with a cash infusion from Kellanova of $1 million. This revision also resulted in immaterial changes to the Consolidated Statement of Income, Consolidated Statement of Comprehensive Income and Consolidated Statement of Equity. This revision does not have any impact to compensation metrics as it relates to periods prior to Spin-Off.

Accounts payable - Supplier Finance Programs

The Company establishes competitive market-based terms with our suppliers, regardless of whether they participate in supplier finance programs, which generally range from 0 to 135 days depending on their respective industry and geography.

The Company has agreements with third parties to provide accounts payable tracking systems which facilitate participating suppliers’ ability to monitor and, if elected, sell payment obligations from the Company to designated third-party financial institutions. Participating suppliers may, at their sole discretion, make offers to sell one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company has no economic interest in the sale of these suppliers’ receivables and no direct financial relationship with the financial institutions concerning these services. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to sell amounts under the arrangements. However, the Company’s right to offset balances due from suppliers against payment obligations is restricted by the agreements for those payment obligations that have been sold by suppliers. The payment of these obligations by the Company is included in cash used in operating activities in the Unaudited Consolidated Statement of Cash Flows. As of March 30, 2024, $128 million of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system. As of December 30, 2023, $142 million of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system.

Disaggregated net sales

The following table presents the Company's disaggregated net sales by country:


	Quarter ended
(millions)	March 30, 2024		April 1, 2023
United States	$	623	$	637
Canada	$	75	$	74
Other	$	9	$	9
Total	$	707	$	720

Accounting standards to be adopted in future periods

Segment Reporting: Improvements to Reportable Segment Disclosures. In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This standard requires all public entities that are subject to segment reporting requirements to disclose additional information, including significant segment expenses and other segment items on an annual and interim basis. It also requires the disclosure of the title and the position of the chief operating decision maker and how the reported measures are used for making business decisions. This standard is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company intends to adopt the updated standard for the fiscal year ending December 28, 2024. The Company is currently evaluating the impact the adoption of this standard will have on its disclosures.

Income Taxes: Improvements to Income Tax Disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This standard expands the disclosure

Table of Contents

requirements primarily on the rate reconciliation and income tax paid. For public entities, this standard is effective for annual reporting periods beginning after December 15, 2024, with early adoption permitted. The Company intends to adopt the updated standard for the fiscal year ending January 3, 2026. The Company is currently evaluating the impact the adoption of this standard will have on its disclosures.

Note 2 Sale of accounts receivable

The Company has a program in which a discrete group of customers are allowed to extend their payment terms in exchange for the elimination of early payment discounts (Extended Terms Program).

The Company has a monetization agreement with an unaffiliated financial institution specifically designed to factor trade receivables with certain customers that participate in the Extended Terms Program. Under this monetization arrangement, from time to time, the Company sells these customers’ trade receivables at a discount on a non-recourse basis. A portion of the cash proceeds is subject to certain restrictions. Transfers under these agreements are accounted for as sales of receivables resulting in the receivables being de-recognized from the Unaudited Consolidated Balance Sheets. The monetization program provides for the continuing sale of certain receivables on a revolving basis until terminated by either party; however, the maximum receivables that may be sold at any time is approximately $350 million.

For all periods prior to the Spin-Off, the Company participated in Kellanova's monetization program and received an allocation of the recorded net loss on sale of receivables, based on the proportion of monetized receivables. Kellanova's program allowed for maximum receivables sold at one time of $1.1 billion.

The Company has no retained interest in the receivables sold; however, the Company does have collection and administrative responsibilities for the receivables sold. The Company has not recorded any servicing assets or liabilities as of March 30, 2024 and December 30, 2023 for these agreements, as the fair value of these servicing arrangements as well as the fees earned were not material to the financial statements.

Accounts receivable sold of $287 million and $266 million remained outstanding under these arrangements as of March 30, 2024 and December 30, 2023, respectively. The proceeds from these sales of receivables are included in net cash provided by (used in) operating activities in the Unaudited Consolidated Statement of Cash Flows in the period of sale. The recorded net loss on sale of receivables was $4 million for the quarter ended March 30, 2024 and $4 million for the quarter ended April 1, 2023. The recorded loss is included in Other income (expense), net ("OIE").

A portion of cash received related to the accounts receivable monetization program is restricted as part of the Extended Terms collateralization agreement. As of March 30, 2024 and December 30, 2023, the amount of restricted cash was $14 million and $13 million, respectively, and is included in Cash and cash equivalents in the Unaudited Consolidated Balance Sheets.

Note 3 Equity

Earnings per share

Basic earnings per share is determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share is similarly determined, except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if all dilutive potential shares of common stock had been issued. Dilutive potential shares of common stock consist principally of unvested restricted stock units. As of March 30, 2024, the Company had approximately one million dilutive shares and no anti-dilutive shares.

On the Spin-Off Date, Kellanova distributed 85,631,304 shares of the Company's common stock to Kellanova's shareowners in connection with the Spin-Off. For comparative purposes, weighted average shares outstanding for the quarter ended April 1, 2023 have been retroactively recast to reflect the effects of the changes in equity structure resulting from the Spin-Off and assume the same basic weighted average shares as of the Spin-Off Date. For periods prior to the Spin-Off, it is assumed that there are no dilutive securities as there were no stock-based awards of the Company outstanding. Refer to the Unaudited Consolidated Statement of Income for basic and diluted earnings per share for the quarters ended March 30, 2024 and April 1, 2023.

Table of Contents

Comprehensive income

Comprehensive income includes net income and all other changes in equity during a period except those resulting from investments by or distributions to shareowners. Other comprehensive income consists of foreign currency translation adjustments, adjustments for net experience gains (losses), prior service credit (costs) related to employee benefit plans, which are recorded in OIE within the statement of income, upon reclassification from Accumulated other comprehensive income ("AOCI"). The related tax effects of these items are recorded in Income taxes within the Unaudited Consolidated Statement of Income, upon reclassification from AOCI.

AOCI as of March 30, 2024 and December 30, 2023 consisted of the following:


(millions)	March 30, 2024		December 30, 2023
Foreign currency translation adjustments	$	(38)	$	(35)


Postretirement and postemployment benefits:

Prior service credit (cost)	6		7

Total accumulated other comprehensive income (loss)	$	(32)	$	(28)

Note 4 Pension and postretirement benefits

The Company sponsors a pension plan in the United States and several plans in the United States and Canada that provide health care and other welfare benefits to retired employees who have met certain age and service requirements. These plans are described within the footnotes to the Consolidated Financial Statements included in the 2023 Annual Report. Components of Company benefit plans (income) expense for the periods presented are included in the tables below. Excluding the service cost component, these amounts are included within OIE in the Unaudited Consolidated Statement of Income.

The following tables present the pension expense and nonpension postretirement income directly attributable to the Company for the quarter ended March 30, 2024:

Pension


	Quarter ended
(millions)	March 30, 2024
Service cost	$	2
Interest cost	7
Expected return on plan assets	(9)
Amortization of unrecognized prior service cost	1

Total pension expense	$	1

Other nonpension postretirement


	Quarter ended
(millions)	March 30, 2024
Service cost	$	1
Interest cost	6
Expected return on plan assets	(15)
Amortization of unrecognized prior service cost	(2)



Total postretirement benefit income	$	(10)

Table of Contents

For the quarter ended April 1, 2023, there were no direct pension and nonpension postretirement costs. The following table summarizes the expenses that were allocated to the Company's plans prior to the Spin-Off:


		Quarter ended
(millions)		April 1, 2023

Pension plan:
Shared plans (multiemployer)	Cost allocation - COGS	$	2
	Cost allocation - OIE	—
Total pension expense		$	2

Nonpension postretirement plan:
Shared plans (multiemployer)	Cost allocation - COGS	$	1
	Cost allocation - OIE	(10)
Total postretirement benefit income		$	(9)

Company contributions to employee benefit plans are summarized as follows:


(millions)	Pension		Nonpension postretirement		Total
Quarter ended:
March 30, 2024	$	3	$	—	$	3
April 1, 2023	$	—	$	—	$	—



Full year:
Fiscal year 2024 (projected) (a)	$	24	$	—	$	24
Fiscal year 2023 (actual)	$	—	$	—	$	—

(a)Projected 2024 amounts have been corrected from $0 million as previously disclosed in our 2023 Annual Report to $24 million.

Plan funding strategies may be modified in response to management's evaluation of tax deductibility, market conditions, and competing investment alternatives.

Note 5 Operating leases

During the first quarter of 2024, the Company entered into a lease agreement with an unrelated third party for a distribution center previously leased by Kellanova. The lease was transferred to the Company from Kellanova as outlined in the Separation and Distribution Agreement. Payments for this lease are made on a monthly basis, with the remaining term extending through 2029. Prior to the execution of this lease, use of this distribution center was managed under the Transition Services Agreement.

The new lease agreement resulted in an increase to operating lease assets of $34 million, which is recorded within Other assets on the Unaudited Consolidated Balance Sheet. This also resulted in an increase to operating lease liabilities of $34 million, of which $3 million is classified as short-term and included in Other current liabilities and $31 million is classified as long-term, which is included in Other liabilities within the Unaudited Consolidated Balance Sheet.

Note 6 Income taxes

The Company's consolidated effective tax rate for the quarter ended March 30, 2024 was 25.9%. The consolidated effective tax rate for the quarter ended April 1, 2023 was 24.3%. The Company's income tax expense is impacted by the level and mix of earnings among tax jurisdictions. The rate differed from the U.S. statutory rate in both periods primarily due to the impact of US state taxes.

Note 7 Derivative instruments

The Company is exposed to certain market risks such as changes in interest rates, foreign currency exchange rates, and commodity prices, which exist as a part of its ongoing business operations. Management uses derivative and nonderivative financial and commodity instruments to manage these risks. Instruments used as hedges must be effective at reducing the risk associated with the exposure being hedged. As a matter of policy, the Company does not engage in trading or speculative hedging transactions.

Table of Contents

Prior to the Spin-Off, the Company participated in Kellanova's hedging program, which uses derivative and nonderivative financial and commodity instruments, including futures, options, and swaps, where appropriate, to manage risks. Since these derivative instruments were entered into and settled by Kellanova for both the Company and Kellanova's other businesses, no asset or liability was recorded on the Company's Unaudited Consolidated Balance Sheets prior to the Spin-Off. However, an appropriate allocation of the gains/losses and fees associated with entering into derivative instruments has been included in the Company's Unaudited Consolidated Statements of Income for each period presented prior to the Spin-Off. The fair value of derivative instruments entered into subsequent to the Spin-Off, which are included within the Unaudited Consolidated Balance Sheet as of March 30, 2024, were immaterial.

The effect of derivative instruments on the Company's Unaudited Consolidated Statement of Income for the quarters ended March 30, 2024 and April 1, 2023 was as follows:


	Gain (loss) recognized in cost of goods sold				Gain (loss) recognized in other income (expense), net
(millions)	March 30, 2024		April 1, 2023		March 30, 2024		April 1, 2023
Commodity Contracts	$	—	$	(6)	$	—	$	—
Foreign Currency derivatives	$	—	$	2	$	—	$	—

Note 8 Supplemental financial statement data

Unaudited Consolidated Balance Sheet


(millions)	March 30, 2024		December 30, 2023
Trade receivables	$	223	$	225
Allowance for expected credit losses	—		—

Other receivables	21		19
Accounts receivable, net	$	244	$	244
Raw materials	$	47	$	49
Manufacturing supplies	53		53
Materials in process	20		15
Finished goods	208		228
Inventories	$	328	$	345
Property, cost	$	2,637	$	2,676
Accumulated depreciation	(1,902)		(1,937)
Property, net	$	735	$	739





Other third party	537		502
Kellanova (a)	7		39
Accounts payable	$	544	$	541
Obligations under Transition Services Agreement	17		52

Operating lease obligations	10		6
Income taxes payable	12		7
Other	51		40
Other current liabilities	$	90	$	105

(a)The $7 million and $39 million payable to Kellanova represents various items Kellanova paid on our behalf, for which we owe reimbursement for amounts incurred related to the Spin-Off.

Table of Contents

Note 9 Contingencies

The Company is subject to various legal proceedings, claims, and governmental inspections or investigations in the ordinary course of business covering matters such as general commercial, governmental regulations, antitrust and trade regulations, product liability, environmental, intellectual property, workers’ compensation, employment and other actions. These matters are subject to uncertainty and the outcome is not predictable with assurance. The Company uses a combination of insurance and self-insurance for a number of risks, including workers’ compensation, general liability, automobile liability and product liability.

The Company establishes accruals when appropriate for certain matters where losses are deemed probable and reasonably estimable. There are other claims and legal proceedings pending against the Company for which accruals have not been established. It is reasonably possible that some of these matters could result in an unfavorable judgment against the Company and could require payment of claims in amounts that cannot be estimated at March 30, 2024. Based upon current information, management does not expect any of the claims or legal proceedings pending against the Company to have a material impact on the Company’s consolidated financial statements.

Table of Contents

WK KELLOGG CO

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to help the reader understand the Company, our operations and our present business environment. MD&A is provided as a supplement to, and should be read in conjunction with, our Unaudited Consolidated Financial Statements and the accompanying notes thereto contained in Part I, Item 1 of this Quarterly Report on Form 10-Q ("Quarterly Report").

Business Overview

WK Kellogg Co is an iconic North American cereal company with a differentiated portfolio of brands that have delighted our consumers for over a century. As a leading manufacturer, marketer and distributor of branded ready-to-eat cereal, we endeavor to provide consumers with high-quality products while promoting consumer health and well-being. Our products are manufactured by us in the United States, Mexico, and Canada and marketed in the United States, Canada, and the Caribbean.

We believe our business' long-standing success is attributable to the strength of our brands, our category expertise, and over a century of institutional knowledge, all of which has created a diverse portfolio of cereals that are intended to enhance the lives of our consumers. Our product offerings are well diversified across the cereal sub-categories of taste, wellness and balance, with strong consumer appeal across the spectrum of ages and demographics. Iconic brands used in our business include Frosted Flakes, Special K, Froot Loops, Raisin Bran, Frosted Mini-Wheats, Rice Krispies, Kashi, Corn Flakes and Apple Jacks, among many others.

Our products are manufactured through our production platform consisting of six primary facilities and are sold through a variety of channels such as grocery stores, mass merchandisers, club stores, and drugstores.

Separation from Kellanova

On October 2, 2023, Kellanova (formerly known as Kellogg Company) completed the spin-off (the "Spin-Off") of its North American cereal business through the distribution of all of the shares of WK Kellogg Co (the "Company") common stock to Kellanova’s share owners at a ratio of one share of the Company's common stock for every four shares of Kellanova’s common stock. Prior to the Spin-Off, the Company underwent an internal reorganization that resulted in it becoming the holder, directly or through its subsidiaries, of the North American cereal business held by Kellanova. Prior to the Spin-Off, the Company was a wholly owned subsidiary of Kellanova.

In connection with the Spin-Off, the Company entered into several agreements with Kellanova that govern the relationship of the parties following the Spin-Off and allocate between the Company and Kellanova various assets, liabilities, and obligations, including, among other things, employee benefits, intellectual property, and tax related assets and liabilities. The agreements included a Separation and Distribution Agreement, Employee Matters Agreement, Supply Agreement, Master Ownership and License Agreements regarding Patents, Trademarks and Certain Related Intellectual Property, Tax Matters Agreement and Transition Services Agreement.

Basis of Presentation

Our MD&A references consumption and net sales in discussing our sales trends for certain brands. We record net sales upon delivery of shipments to our customers. Consumption refers to consumer purchases of our products from our customers.

Key Factors Affecting Our Business

We believe key industry and economic factors that are currently impacting our business, and which in the near term are expected to continue to impact our business, include the following:

Macroeconomic conditions. Geopolitical instability, including wars and conflicts, as well as other global events have resulted in certain impacts to the global economy, including market disruptions, supply chain challenges and inflationary pressures. We continue to experience some elevated commodity and supply chain costs, although

Table of Contents

certain supply chain challenges have eased. We were able to mostly offset the dollar impact of this input-cost inflation through the execution of productivity initiatives and the implementation of revenue growth management actions to realize price. Additionally, from time to time, we may enter into a combination of fixed price contracts with supplier and commodity derivative instruments to manage the impact of volatility in the price of raw materials.

The war in Ukraine and the related sanctions, along with the conflict in the Middle East, have increased global economic and geopolitical uncertainty. The Company is a North American-focused company with no direct exposure to Russia, Ukraine or the Middle East. However, sanctions imposed by the United States on Russian oil and gas imports, as well as disruption to Ukraine’s wheat and other agricultural supply due to the ongoing military conflict, could cause further inflation of our commodity costs.

Highly competitive environment. Our business is concentrated primarily in a single product category that faces intense competition. The principal aspects of our business where we experience competition include brand recognition, taste, nutritional value, price, promotion, innovation, shelf space and customer service. We have competition from both branded and private label product offerings. Our ability to successfully compete in the marketplace is dependent on our strategic execution on the items above.

Challenging retail environment. Our business is largely concentrated in the traditional retail grocery trade with a significant percentage of our sales coming from a small group of large U.S. retail customers. The U.S. retail environment continues to face further consolidation. We must leverage our marketing expertise, product innovation and category leadership position to respond to our customers and provide high service levels.

These factors contribute to a market environment of intense competition, constant product innovation and continuing cost pressure that creates a challenging commercial and economic environment. We continually evaluate these factors as we develop and execute our strategies.

Non-GAAP Financial Measures

The non-GAAP financial measures in this Quarterly Report are supplemental measures of our performance. These measures that we provide to management and investors exclude certain items that we do not consider part of on-going operations. Our management team utilizes a combination of GAAP and non-GAAP financial measures to evaluate business results, to make decisions regarding the future direction of our business, and for resource allocation decisions, including incentive compensation. As a result, we believe the presentation of both GAAP and non-GAAP financial measures provides investors with increased transparency into financial measures used by our management team and improves investors’ understanding of our underlying operating performance and analysis of ongoing operating trends. All historical non-GAAP financial measures have been reconciled from the most directly comparable U.S. GAAP financial measures.

As non-GAAP financial measures are not standardized, they may not be comparable to financial measures used by other companies or to non-GAAP financial measures having the same or similar names. In order to compensate for such limitations of non-GAAP measures, readers should review the reconciliations and should not consider these measures in isolation from, or as alternatives to, the comparable financial measures determined in accordance with GAAP.

•Adjusted Earnings Before Interest, Taxes, Deprecation and Amortization ("EBITDA"): We adjust the GAAP net income (loss) for: interest expense, income tax expense (benefit), depreciation and amortization expense, mark-to-market impacts from commodity and foreign currency contracts, other income (expense), net, separation costs related to the Spin-Off and business and portfolio realignment costs. Management believes that these metrics provide investors an additional basis to assess results over time.

•Adjusted gross profit and adjusted gross margin: We adjust GAAP gross profit and gross margin to exclude the effect of business and portfolio realignment costs, separation costs related to the Spin-Off and mark-to-market impacts from commodity and foreign currency contracts. We exclude items which we believe may obscure trends in our underlying profitability. By providing these non-GAAP profitability measures, management believes that investors are provided with a more meaningful, consistent comparison of the Company's profitability measures for the periods presented. Management uses these non-GAAP financial measures to evaluate the effectiveness of initiatives intended to improve profitability, as well as to evaluate the impacts of inflationary pressures and decisions to invest in new initiatives.

Table of Contents

•Free cash flow: Free cash flow is defined as net cash provided by operating activities reduced by expenditures for property additions. Cash flow does not represent the residual cash flow available for discretionary expenditures. We use this non-GAAP financial measure of cash flow to focus management and investors on the amount of cash available for debt repayment, dividend distributions, acquisition opportunities, and share repurchases once all of the Company’s business needs and obligations are met.

Significant items impacting comparability

Mark-to-market on foreign exchange and commodity hedges

The Company recognizes mark-to-market adjustments for commodity contracts and certain foreign currency contracts as incurred. Changes between contract and market prices for commodity contracts and certain foreign currency contracts result in gains/losses that are recognized in the quarter they occur. The Company did not incur any material pre-tax mark-to-market impacts for the quarter ended March 30, 2024. The Company recorded a pre-tax mark-to-market loss of $5 million for the quarter ended April 1, 2023.

Separation costs

The Company incurred pre-tax charges related to the Spin-Off, primarily related to spin-related employee costs and TSA transition costs of $9 million for the quarter ended March 30, 2024. The Company recorded separation costs, primarily related to legal and consulting costs, of $23 million for the quarter ended April 1, 2023.

Business and portfolio realignment

The Company incurred non-recurring costs related to a reconfiguration of our supply chain network designed to drive increased productivity, resulting in pre-tax charges of $1 million for the quarter ended March 30, 2024. The Company did not incur any pre-tax costs in connection with its business and portfolio realignment for the quarter ended April 1, 2023.

Other income (expense), net

The Company excludes the impact of all non-operating items from its Adjusted EBITDA calculation, which primarily includes pension-related income (expense), net and financing fees. As a result, other income of $6 million was excluded for the quarter ended March 30, 2024. Other income of $8 million was excluded for the quarter ended April 1, 2023.

Net income

The following tables provide an analysis of net income performance for the quarters ended March 30, 2024 and April 1, 2023:


	Quarter ended
(millions)	March 30, 2024		April 1, 2023
Reported net income	$	33	$	24
Interest expense	8		—
Income tax expense (benefit)	11		8
Depreciation and amortization expense	19		17

EBITDA	$	71	$	49
(Gain) loss on mark-to-market foreign exchange and commodity hedges	—		5
Other (income) expense, net	(6)		(8)
Separation costs	9		23
Business and portfolio realignment costs	1		—
Adjusted EBITDA	$	75	$	69

Note: Tables may not foot due to rounding.

Table of Contents

Net income for the quarter ended March 30, 2024 increased approximately 38% as a result of productivity and revenue growth management initiatives, which was slightly mitigated by an increase in interest expense of $8 million. After excluding the impacts of income tax expense, interest expense and depreciation, our EBITDA increased 45% compared to the prior period, primarily driven by a decrease in separation costs of $14 million when compared to the prior period. Adjusted EBITDA, which excludes the impacts of mark-to-market, other (income) expense, business and portfolio realignment costs and separation costs, increased 9% compared to the prior period.

Margin performance

Our gross profit and gross profit margin performance for the quarters ended March 30, 2024 and April 1, 2023 were as follows:


Quarter ended	March 30, 2024				April 1, 2023				GM change vs. prior year (pts.)
(millions)	Gross Profit (a)		Gross Margin (b)		Gross Profit (a)		Gross Margin (b)
Reported	$	203	28.7	%	$	180	25.0	%	3.7
Mark-to-market	—		—	%	5		0.7	%	(0.7)
Separation costs	3		0.4	%	3		0.4	%	—

Business and portfolio realignment	1		0.1	%	—		—	%	0.1

Adjusted	$	207	29.2	%	$	188	26.1	%	3.1

Note: Tables may not foot due to rounding.

(a) Gross profit is equal to net sales less cost of goods sold.

(b) Gross profit as a percentage of net sales.

Reported gross margin for the quarter increased 370 basis points versus the prior year due primarily to the impact of productivity and revenue growth management initiatives. Adjusted gross margin increased 310 basis points, which excludes mark-to market impacts on commodities and foreign exchange hedges, business and portfolio realignment costs and separation costs.

Net sales


	Quarter ended
(millions)	March 30, 2024			April 1, 2023
Net sales	$	707		$	720




























% change - 2024 vs. 2023:
Net sales increase (decrease)	(1.9)		%











Volume (tonnage)	(7.0)		%
Pricing/mix	5.1		%

Note: Tables may not foot due to rounding.

Net sales for the quarter ended March 30, 2024 decreased approximately 2%. Volume declined 7% compared to the prior year, reflecting price elasticity. This decline in volume was offset by revenue growth management initiatives designed to cover rising input-cost inflation, resulting in a favorable price/mix of approximately 5%.

Selling, general and administrative expense


	Quarter ended
(millions)	March 30, 2024			April 1, 2023
Selling, general & administrative expense	$	157		$	156




























% change - 2024 vs. 2023:
Selling, general & administrative expense increase (decrease)	0.6		%

Selling, general and administrative expense for the quarter ended March 30, 2024 increased approximately 1%. Expense for the first quarters of 2024 and 2023 was 22% of net sales.

Table of Contents

Other income (expense), net

Other income (expense), net consists primarily of allocated pension and postretirement benefit plan related mark-to-market, interest cost, and expected return on plan assets.

For the quarter ended March 30, 2024, other income (expense), net decreased by 25% to $6 million compared to $8 million in the quarter ended April 1, 2023. The primary driver of this decrease was $2 million in insurance proceeds received in the prior year related to recoveries for property damage after a fire at one of our manufacturing facilities.

Income taxes

Liquidity and capital resources

In September of 2023, the Company entered into a Credit Agreement, consisting of a $500 million term loan (the "Term Loan"), a $250 million delayed draw term loan, and a $350 million equivalent multicurrency revolving credit facility (collectively, the “Credit Facility”). As of March 30, 2024, borrowings under the Credit Facility were $497 million comprised of the Term Loan, of which $8 million was recognized as the current portion, less upfront fees paid during debt issuance. As of March 30, 2024, there was an additional $600 million of borrowing capacity under the Credit Facility.

In May of 2024 the Board of Directors declared a dividend of $0.16 per share of common stock, payable on June 14, 2024 to shareowners of record as of the close of business on May 31, 2024.

Our ability to fund our operating needs will depend on our future ability to continue to generate positive cash flow from operations and on our ability to obtain debt financing on acceptable terms. Management believes that our cash balances and funds provided by operating activities, along with borrowing capacity under the Credit Facility and access to capital markets, taken as a whole, provide (i) adequate liquidity to meet all of our current and long-term obligations when due, including third-party debt that was incurred in connection with the Spin-Off, (ii) adequate liquidity to fund capital expenditures primarily utilized in manufacturing our products, and (iii) flexibility to meet investment opportunities that may arise. However, our access to, and the availability of, financing on acceptable terms and conditions in the future will be impacted by many factors, including (1) our credit ratings, including the lowering of any of our credit ratings, or absence of a credit rating, (2) the liquidity of the overall capital markets and (3) the future state of the U.S. and global economy and, accordingly, there can be no assurances that we will be able to obtain additional debt or equity financing on acceptable terms in the future, or at all.

We believe our operating cash flow, together with borrowings currently available under our Credit Facility, will be adequate to meet our operating, investing and financing needs in the foreseeable future, and at a minimum for the next 12 months. We plan to utilize such flexibility to drive an investment philosophy that balances capital investments in areas such as supply chain optimization, cost-saving projects and new capabilities, with the ability to further increase shareowner value through a combination of debt reduction, return of capital to our shareowners in the form of dividends as well as potential acquisitions. In the near term we may increase our indebtedness to fund important capital projects. Thereafter, however, we anticipate being able to reduce indebtedness as a way to increase our financial flexibility and enhance shareowner value.

Table of Contents

The following table sets forth a summary of our cash flows:


	Year-to-date period ended
(millions)	March 30, 2024		April 1, 2023
Net cash provided by (used in):
Operating activities	10		$	62
Investing activities	(9)		(31)
Financing activities	(19)		(30)
Effect of exchange rates on cash and cash equivalents	—		—
Net increase (decrease) in cash and cash equivalents	$	(18)	$	1

Operating activities

Cash flow from operating activities for the quarter ended March 30, 2024, decreased to $10 million, compared to $62 million in the prior year. The decrease was primarily due to the return to normalized inventory levels after lapping impacts that were impactful to the year-ended 2022 which included cost inflation, general supply disruption and rebuild of inventory balances following a fire and strike at our manufacturing facilities in 2021, as well as the settlement of $32 million of transition payables balances due to Kellanova in the first quarter of 2024, pursuant to the Transition Services Agreement.

We measure free cash flow as net cash provided by operating activities, reduced by expenditures for property additions. We use this non-GAAP financial measure of cash flow to focus management and investors on the amount of cash available for debt repayment, dividend distributions, acquisition opportunities and share repurchases. Our cash flow metric is reconciled to the most comparable GAAP measure below:


	Quarter ended
(millions)	March 30, 2024		April 1, 2023
Net cash provided by operating activities	$	10	$	62
Additions to properties	(9)		(31)
Free cash flow	$	1	$	31

Investing activities

Our net cash used in investing activities was $9 million for the quarter ended March 30, 2024 compared to $31 million in the comparable prior year period due to timing of capital spending in the current year compared to prior year.

Financing activities

Our net cash used in financing activities for the quarter ended March 30, 2024 was $19 million compared to net cash used of $30 million during the comparable prior year period. The current year transactions primarily include $14 million of dividend payments to shareowners in the first quarter of 2024 and $6 million in repayments on credit borrowings compared to $30 million in net transfers to Kellanova in the prior year.

Monetization and Supplier Finance Programs

The Company maintains a monetization agreement with an unaffiliated financial institution specifically designed to factor trade receivables with certain customers that have extended terms. Under this monetization arrangement, from time to time, the Company sells these customers’ trade receivables at a discount on a non-recourse basis. A portion of the cash proceeds is subject to certain restrictions. Transfers under these agreements are accounted for as sales of receivables resulting in the receivables being de-recognized from the Unaudited Consolidated Balance Sheet. The monetization program provides for the continuing sale of certain receivables on a revolving basis until the arrangement is terminated by either party; however, the maximum receivables that may be sold at any time is approximately $350 million. Prior to the Spin-Off, the Company participated in Kellanova's monetization program, which was structured similarly but resulted in a higher level of receivables allowed to be sold when compared to the current program in place.

The Company has no retained interest in the receivables sold; however, the Company does have collection and administrative responsibilities for the sold receivables. The Company has not recorded any servicing assets or liabilities as of March 30, 2024 and December 30, 2023 for these agreements as the fair value of these servicing arrangements as well as the fees earned were not material to the financial statements. Accounts receivable sold of

Table of Contents

$287 million and $266 million remained outstanding under these arrangements as of March 30, 2024 and December 30, 2023, respectively. The proceeds from these sales of receivables are included in cash from operating activities in the Consolidated Statement of Cash Flows. The recorded net loss on sale of receivables was $4 million and $4 million for the quarters ended March 30, 2024 and April 1, 2023, respectively. The recorded loss is included in Other income (expense), net.

The Company also has agreements with third parties to provide accounts payable tracking systems which facilitate participating suppliers’ ability to monitor and, if elected, sell payment obligations from the Company to designated third-party financial institutions. Participating suppliers may, at their sole discretion, make offers to sell one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company’s goal is to capture overall supplier savings, in the form of payment terms or vendor funding, and the agreements facilitate the suppliers’ ability to sell payment obligations, while providing them with greater working capital flexibility. The Company has no economic interest in the sale of these suppliers’ receivables and no direct financial relationship with the financial institutions concerning these services. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to sell amounts under the arrangements. However, the Company’s right to offset balances due from suppliers against payment obligations is restricted by the agreements for those payment obligations that have been sold by suppliers.

The payment of these obligations by the Company is included in cash provided by (used in) operating activities in the Unaudited Consolidated Statement of Cash Flows. As of March 30, 2024, $128 million of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system. As of December 30, 2023, $142 million of the Company’s outstanding payment obligations had been placed in the accounts payable tracking system.

Critical accounting estimates

We have included a summary of our critical accounting estimates in our 2023 Annual Report. There have been no material changes to the summary provided in that report.

Forward-looking statements

This Quarterly Report contains a number of “forward-looking statements” with expectations concerning, among other things, the results of the Spin-Off; our strategy, financial principles, and plans; initiatives, improvements and growth; sales, margins, advertising, promotion, merchandising, brand building, operating profit, and earnings per share; innovation; investments; capital expenditures; asset write-offs and expenditures and costs related to productivity or efficiency initiatives; the impact of accounting changes and significant accounting estimates; our ability to meet interest and debt principal repayment obligations; minimum contractual obligations; future common stock repurchases or debt reduction; effective income tax rate; cash flow and core working capital improvements; interest expense; commodity and energy prices; and employee benefit plan costs and funding. Forward-looking statements include predictions of future results or activities and may contain the words “expect,” “believe,” “will,” “can,” “anticipate,” “estimate,” “project,” “should,” or words or phrases of similar meaning. For example, forward-looking statements are found in several sections of this MD&A. Our actual results or activities may differ materially from these predictions.

Our future results could be affected by a variety of other factors, including a decline in demand for ready-to-eat cereals; supply chain disruptions and increases in costs and/or shortages of raw materials, labor, fuels and utilities as a result of geopolitical, economic and market conditions; consumers’ perception of our brands or company; business disruptions; our ability to drive our growth targets to increase revenue and profit; our failure to achieve our targeted cost savings and efficiencies from cost reduction initiatives; strategic acquisitions, alliances, divestitures or joint ventures or organic growth opportunities we may pursue in the future; material disruptions at one of our facilities; our ability to attract, develop and retain the skilled people we need to support our business; a shortage of labor, our failure to successfully negotiate collectively bargained agreements, or other general inflationary pressures or changes in applicable laws and regulations that could increase labor costs; an increase in our post-retirement benefit-related costs and funding requirements caused by, among other things, volatility in the financial markets, changes in interest rates and actuarial assumptions; our inability to obtain sufficient capital to grow our business and to increase our revenues; an impairment of the carrying value of goodwill or other acquired intangibles; increases in the price of raw materials, including agricultural commodities, packaging, fuel and labor; increases in transportation costs and reduced availability of, or increases in, the price of oil or other fuels; competition, including with respect to retail and shelf space; the changing retail environment and the growing presence of alternative retail

Table of Contents

channels; the successful development of new products and processes; adverse changes in the global climate or extreme weather conditions; and other risks and uncertainties described in Part I, Item 1A, of our 2023 Annual Report. Forward-looking statements speak only as of the date of this Quarterly Report, and we undertake no obligation to publicly update them except as required by law.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Our company is exposed to certain market risks, which exist as a part of our ongoing business operations. We use derivative financial and commodity instruments, where appropriate, to manage these risks. As a matter of policy, we do not engage in trading or speculative transactions. Refer to Note 7 within Notes to Unaudited Consolidated Financial Statements for further information on our derivative financial and commodity instruments.

Refer to disclosures contained within Part I, Item 7A of our 2023 Annual Report. There have been no material changes in the Company’s market risk during the quarter ended March 30, 2024.

Item 4. Controls and Procedures

Management of the Company, with the participation of its Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the period ending March 30, 2024. Based upon our evaluation, our CEO and our CFO have concluded that, as of the period ending March 30, 2024, our disclosure controls and procedures were effective and provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our CEO and our CFO, as appropriate, to allow timely decisions regarding required disclosure.

No changes in our internal controls over financial reporting during the quarter ended March 30, 2024 have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Table of Contents

PART II — OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A to our 2023 Annual Report. The risk factors disclosed in the 2023 Annual Report in addition to the other information set forth in this Quarterly Report, could materially affect our business, financial condition, or results.

Item 5. Other Information

Insider Trading Arrangements

During the most recent fiscal quarter, none of our directors or officers subject to Section 16 of the Exchange Act adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act and/or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).

Table of Contents

Item 6. Exhibits

(a)Exhibits:



10.1			WK Kellogg Co Annual Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on February 13, 2024).
10.2			Form of Restricted Share Unit Terms and Conditions (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on February 13, 2024).
10.3			Form of Performance Stock Unit Terms and Conditions (incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K filed with the SEC on February 13, 2024).
10.4			WK Kellogg Co Executive Severance Benefit Plan (incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K filed with the SEC on February 13, 2024).
10.5			WK Kellogg Co Change of Control Severance Policy for Key Executives (as amended, effective as of February 8, 2024) (incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K filed with the SEC on February 13, 2024).
10.6			WK Kellogg Co Amended and Restated 2023 Long-Term Equity Incentive Plan (incorporated herein by reference to Annex B to the Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 21, 2024).
31.1			Rule 13a-14(e)/15d-14(a) Certification of Gary Pilnick
31.2			Rule 13a-14(e)/15d-14(a) Certification of David McKinstray
32.1			Section 1350 Certification of Gary Pilnick
32.2			Section 1350 Certification of David McKinstray
101.INS			Inline XBRL Instance Document
101.SCH			Inline XBRL Taxonomy Extension Schema Document
101.CAL			Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF			Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB			Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE			Inline XBRL Taxonomy Extension Presentation Linkbase Document
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Table of Contents

WK KELLOGG CO

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


WK KELLOGG CO

/s/ David McKinstray
David McKinstray
Chief Financial Officer

/s/ Lisa Walter
Lisa Walter
Principal Accounting Officer; Corporate Controller

Date: May 7, 2024

Exhibit 31.1

CERTIFICATION

I, Gary Pilnick, certify that:

1.I have reviewed this quarterly report on Form 10-Q of WK Kellogg Co;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



			/s/ Gary Pilnick
			Name: Gary Pilnick
			Title: Chief Executive Officer and Chair of the Board

Date: May 7, 2024

Exhibit 31.2

CERTIFICATION

I, David McKinstray, certify that:

1.I have reviewed this quarterly report on Form 10-Q of WK Kellogg Co;

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



			/s/ David McKinstray
			Name: David McKinstray
			Title: Chief Financial Officer

Date: May 7, 2024

Exhibit 32.1

SECTION 1350 CERTIFICATION

I, Gary Pilnick, hereby certify, on the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that

(1)the Quarterly Report on Form 10-Q of WK Kellogg Co for the quarter ended March 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of WK Kellogg Co.


/s/ Gary Pilnick
Name:			Gary Pilnick
Title:			Chief Executive Officer and Chair of the Board

Date: May 7, 2024

Exhibit 32.2

SECTION 1350 CERTIFICATION

I, David McKinstray, hereby certify, on the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of WK Kellogg Co.


/s/ David McKinstray
Name:			David McKinstray
Title:			Chief Financial Officer

Date: May 7, 2024

Cover Page - shares	3 Months Ended
Cover Page - shares	Mar. 30, 2024	May 01, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 30, 2024
Document Transition Report	false
Entity File Number	001-41755
Entity Registrant Name	WK Kellogg Co
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	92-1243173
Entity Address, Address Line One	One Kellogg Square
Entity Address, City or Town	Battle Creek
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	49016-3599
City Area Code	269
Local Phone Number	401-3000
Title of 12(b) Security	Common Stock, $.0001 par value per share
Trading Symbol	KLG
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		85,877,528
Amendment Flag	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Entity Central Index Key	0001959348
Current Fiscal Year End Date	--12-28

CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Current assets
Cash and cash equivalents	$ 70	$ 89
Accounts receivable, net	244	244
Inventories	328	345
Other current assets	22	28
Total current assets	664	706
Property, net	735	739
Goodwill	53	53
Other intangibles	57	57
Postretirement plan assets	292	283
Other assets	87	51
Total assets	1,888	1,889
Current liabilities
Notes payable	2	4
Current maturities of long-term debt	8	8
Accounts payable	544	541
Accrued advertising and promotion	109	121
Accrued salaries and wages	36	57
Other current liabilities	90	105
Total current liabilities	789	836
Long-term debt	484	487
Deferred income taxes	107	106
Pension liability	133	135
Other liabilities	58	25
Commitments and contingencies (Note 9)
Equity
Common stock, $0.0001 par value, $1,000,000,000 shares authorized Issued: $85,808,508 shares in 2024 and $85,812,883 shares in 2023	0	0
Capital in excess of par value	329	327
Retained earnings	20	1
Accumulated other comprehensive loss	(32)	(28)
Total equity	317	300
Total liabilities and equity	$ 1,888	$ 1,889

CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares	Mar. 30, 2024	Dec. 30, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Actual shares outstanding at period end (in shares)	85,808,508	85,812,883

CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
shares in Millions, $ in Millions

3 Months Ended

Mar. 30, 2024

Apr. 01, 2023

Income Statement [Abstract]

Net sales

$ 707

$ 720

Cost of goods sold

504

540

Selling, general and administrative expense

157

156

Operating profit

Interest expense

Other income (expense), net

Income before income taxes

Income taxes

Net income

$ 33

$ 24

Per share amounts:

Basic earnings (in dollars per share)

^[1]

$ 0.38

$ 0.28

Diluted earnings (in dollars per share)

^[1]

$ 0.37

$ 0.28

Average shares outstanding:

Basic (in shares)

Diluted (in shares)

Actual shares outstanding at period end (in shares)

[1]

On October 2, 2023, Kellanova, the former parent company of WK Kellogg Co, distributed 85,631,304 shares of WK Kellogg Co common stock to Kellanova's shareowners in connection with its Spin-Off of WK Kellogg Co (the "Spin-Off"). See Note 1 "Accounting Policies" to the Unaudited Consolidated Financial Statements for more information. Basic and diluted earnings per share were retrospectively recast for the number of shares of WK Kellogg Co common stock outstanding immediately following the Spin-Off for the quarter ended April 1, 2023.

CONSOLIDATED STATEMENTS OF INCOME (Parenthetical)	Oct. 02, 2023 shares
Stock issued during period, new issues (in shares)	85,631,304
Kellenova
Stock issued during period, new issues (in shares)	85,631,304

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Pre-tax amount
Income before income taxes	$ 44	$ 32
Foreign currency translation adjustments:
Foreign currency translation adjustments during period	(3)	2
Reclassification to net income:
Prior service cost	(1)
Comprehensive income	40	34
Tax (expense) benefit
Net income	(11)	(8)
Foreign currency translation adjustments:
Foreign currency translation adjustments during period	1	0
Reclassification to net income:
Prior service cost	0
Comprehensive income	(10)	(8)
After-tax amount
Net income	33	24
Foreign currency translation adjustments:
Foreign currency translation adjustments during period	(2)	2
Reclassification to net income:
Prior service cost	(1)
Comprehensive income	$ 30	$ 26

CONSOLIDATED STATEMENT OF EQUITY (unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common stock	Net Parent Investment	Capital in excess of par value	Retained earnings	Accumulated other comprehensive income (loss)
Balance at Dec. 31, 2022	$ 687		$ 725	$ 0	$ 0	$ (38)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	24		24
Net transfer (to)/from Kellanova	(36)		(36)
Other comprehensive income (loss)	2					2
Balance at Apr. 01, 2023	677		$ 713	0	0	(36)
Balance (in shares) at Dec. 30, 2023		86
Balance at Dec. 30, 2023	300	$ 0		327	1	(28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	33				33
Dividends declared ($0.16 per share)	(14)				(14)
Other comprehensive income (loss)	(4)					(4)
Stock compensation	1			1
Share issuance	1			1
Balance (in shares) at Mar. 30, 2024		86
Balance at Mar. 30, 2024	$ 317	$ 0		$ 329	$ 20	$ (32)

CONSOLIDATED STATEMENT OF EQUITY (unaudited) (Parenthetical)	3 Months Ended
	Mar. 30, 2024 $ / shares
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.16

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Operating activities
Net income	$ 33	$ 24
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	19	17
Postretirement plan benefit	(9)	(7)
Deferred income taxes	1	0
Stock compensation	1	1
Other	3	0
Pension plan contributions	(3)	0
Changes in operating assets and liabilities:
Trade receivables	2	7
Inventories	16	57
Accounts payable	(5)	(23)
Income taxes payable	4	0
Accrued advertising and promotion	(11)	(2)
Accrued salaries and wages	(21)	(8)
All other current assets and liabilities	(20)	(4)
Net cash provided by (used in) operating activities	10	62
Investing activities
Additions to properties	(9)	(31)
Net cash provided by (used in) investing activities	(9)	(31)
Financing activities
Repayment of borrowings under the Credit Agreement	(3)	0
Issuance (repayment) of notes payables, with maturities less than 90 days	(3)	0
Net issuances of common stock	1	0
Dividends paid	(14)	0
Net transfers (to) from Kellanova	0	(30)
Net cash provided by (used in) financing activities	(19)	(30)
Effect of exchange rate changes on cash and cash equivalents		0
Increase (decrease) in cash and cash equivalents	(18)	1
Cash and cash equivalents at beginning of period	88	0
Cash and cash equivalents at end of period	70	1
Supplemental cash flow disclosures of non-cash investing activities:
Additions to properties included in accounts payable	$ 20	$ 27

Accounting policies

3 Months Ended

Mar. 30, 2024

Accounting Policies [Abstract]

Accounting policies

Basis of presentation

The allocation of expenses from Kellanova to the Company was reflected as follows in the Unaudited Consolidated Statement of Operations for the quarter ended April 1, 2023:


	Quarter ended
(millions)	April 1, 2023
Cost of goods sold	$	55
Selling, general and administrative	85
Other (income) expense, net	(6)
Total	$	134

The components of net parent investment for the quarter ended April 1, 2023 are:


(millions)	April 1, 2023
Net transfers (to)/from Kellanova as reflected in the Unaudited Combined Statement of Cash Flow	$	(30)
Non-cash stock compensation expense	1
Non-cash pension and postretirement benefit	(7)
Net transfers from/(to) Kellanova as reflected in the Unaudited Combined Statement of Changes in Equity	$	(36)

Accounts payable - Supplier Finance Programs

Disaggregated net sales

The following table presents the Company's disaggregated net sales by country:


	Quarter ended
(millions)	March 30, 2024		April 1, 2023
United States	$	623	$	637
Canada	$	75	$	74
Other	$	9	$	9
Total	$	707	$	720

Accounting standards to be adopted in future periods

Sale of accounts receivable	3 Months Ended
Sale of accounts receivable	Mar. 30, 2024
Transfers and Servicing of Financial Assets [Abstract]
Sale of accounts receivable	Sale of accounts receivable The Company has a program in which a discrete group of customers are allowed to extend their payment terms in exchange for the elimination of early payment discounts (Extended Terms Program). The Company has a monetization agreement with an unaffiliated financial institution specifically designed to factor trade receivables with certain customers that participate in the Extended Terms Program. Under this monetization arrangement, from time to time, the Company sells these customers’ trade receivables at a discount on a non-recourse basis. A portion of the cash proceeds is subject to certain restrictions. Transfers under these agreements are accounted for as sales of receivables resulting in the receivables being de-recognized from the Unaudited Consolidated Balance Sheets. The monetization program provides for the continuing sale of certain receivables on a revolving basis until terminated by either party; however, the maximum receivables that may be sold at any time is approximately $350 million. For all periods prior to the Spin-Off, the Company participated in Kellanova's monetization program and received an allocation of the recorded net loss on sale of receivables, based on the proportion of monetized receivables. Kellanova's program allowed for maximum receivables sold at one time of $1.1 billion. The Company has no retained interest in the receivables sold; however, the Company does have collection and administrative responsibilities for the receivables sold. The Company has not recorded any servicing assets or liabilities as of March 30, 2024 and December 30, 2023 for these agreements, as the fair value of these servicing arrangements as well as the fees earned were not material to the financial statements. Accounts receivable sold of $287 million and $266 million remained outstanding under these arrangements as of March 30, 2024 and December 30, 2023, respectively. The proceeds from these sales of receivables are included in net cash provided by (used in) operating activities in the Unaudited Consolidated Statement of Cash Flows in the period of sale. The recorded net loss on sale of receivables was $4 million for the quarter ended March 30, 2024 and $4 million for the quarter ended April 1, 2023. The recorded loss is included in Other income (expense), net ("OIE"). A portion of cash received related to the accounts receivable monetization program is restricted as part of the Extended Terms collateralization agreement. As of March 30, 2024 and December 30, 2023, the amount of restricted cash was $14 million and $13 million, respectively, and is included in Cash and cash equivalents in the Unaudited Consolidated Balance Sheets.

Equity

3 Months Ended

Mar. 30, 2024

Equity [Abstract]

Equity

Earnings per share

Comprehensive income

AOCI as of March 30, 2024 and December 30, 2023 consisted of the following:


(millions)	March 30, 2024		December 30, 2023
Foreign currency translation adjustments	$	(38)	$	(35)


Postretirement and postemployment benefits:

Prior service credit (cost)	6		7

Total accumulated other comprehensive income (loss)	$	(32)	$	(28)

Pension and postretirement benefits

3 Months Ended

Mar. 30, 2024

Retirement Benefits [Abstract]

Pension and postretirement benefits

The following tables present the pension expense and nonpension postretirement income directly attributable to the Company for the quarter ended March 30, 2024:

Pension


	Quarter ended
(millions)	March 30, 2024
Service cost	$	2
Interest cost	7
Expected return on plan assets	(9)
Amortization of unrecognized prior service cost	1

Total pension expense	$	1

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Sale of accounts receivable (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Dec. 30, 2023	Oct. 01, 2023
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfers of accounts receivable agreements	$ 350			$ 1,100
Restricted cash	14		$ 13
Other income (expense)
Transfer of Financial Assets Accounted for as Sales [Line Items]
Gain (loss) on sale of accounts receivable	4	$ 4
Sold And Outstanding
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfer of financial assets accounted for as sales, amount derecognized	$ 287		$ 266

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

KLG WK Kellogg Co

WK Kellogg Co News

Your Recent History

Company

Business

Popular

Get The App

Operating leases	3 Months Ended
Operating leases	Mar. 30, 2024
Leases [Abstract]
Operating leases	Operating leases During the first quarter of 2024, the Company entered into a lease agreement with an unrelated third party for a distribution center previously leased by Kellanova. The lease was transferred to the Company from Kellanova as outlined in the Separation and Distribution Agreement. Payments for this lease are made on a monthly basis, with the remaining term extending through 2029. Prior to the execution of this lease, use of this distribution center was managed under the Transition Services Agreement. The new lease agreement resulted in an increase to operating lease assets of $34 million, which is recorded within Other assets on the Unaudited Consolidated Balance Sheet. This also resulted in an increase to operating lease liabilities of $34 million, of which $3 million is classified as short-term and included in Other current liabilities and $31 million is classified as long-term, which is included in Other liabilities within the Unaudited Consolidated Balance Sheet.

Income taxes	3 Months Ended
Income taxes	Mar. 30, 2024
Income Tax Disclosure [Abstract]
Income taxes	Income taxes The Company's consolidated effective tax rate for the quarter ended March 30, 2024 was 25.9%. The consolidated effective tax rate for the quarter ended April 1, 2023 was 24.3%. The Company's income tax expense is impacted by the level and mix of earnings among tax jurisdictions. The rate differed from the U.S. statutory rate in both periods primarily due to the impact of US state taxes.

Contingencies	3 Months Ended
Contingencies	Mar. 30, 2024
Loss Contingency [Abstract]
Contingencies	Contingencies The Company is subject to various legal proceedings, claims, and governmental inspections or investigations in the ordinary course of business covering matters such as general commercial, governmental regulations, antitrust and trade regulations, product liability, environmental, intellectual property, workers’ compensation, employment and other actions. These matters are subject to uncertainty and the outcome is not predictable with assurance. The Company uses a combination of insurance and self-insurance for a number of risks, including workers’ compensation, general liability, automobile liability and product liability. The Company establishes accruals when appropriate for certain matters where losses are deemed probable and reasonably estimable. There are other claims and legal proceedings pending against the Company for which accruals have not been established. It is reasonably possible that some of these matters could result in an unfavorable judgment against the Company and could require payment of claims in amounts that cannot be estimated at March 30, 2024. Based upon current information, management does not expect any of the claims or legal proceedings pending against the Company to have a material impact on the Company’s consolidated financial statements.

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	Mar. 30, 2024	Apr. 01, 2023
Pay vs Performance Disclosure
Net income	$ 33	$ 24

Accounting policies - Allocation of Expenses from Parent (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cost of goods sold	$ 504	$ 540
Selling, general and administrative expense	157	$ 156
Kellanova
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cost of goods sold	55
Selling, general and administrative expense	85
Other (income) expense, net	(6)
Total	$ 134

Accounting policies - Disaggregated net sales (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 707	$ 720
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	623	637
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	75	74
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 9	$ 9

Equity - Narrative (Details) - shares		3 Months Ended
Equity - Narrative (Details) - shares	Oct. 02, 2023	Mar. 30, 2024
Equity [Abstract]
Weighted average number of shares outstanding, diluted, adjustment (in shares)		1,000,000
Anti-dilutive potential common shares excluded from reconciliation (in shares)		0
Stock issued during period, new issues (in shares)	85,631,304

Equity - Summary of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments	$ (38)	$ (35)
Postretirement and postemployment benefits:
Prior service credit (cost)	6	7
Total accumulated other comprehensive income (loss)	$ (32)	$ (28)

Pension and postretirement benefits - Components of Plan Benefit Expense (Details) $ in Millions	3 Months Ended
	Apr. 01, 2023 USD ($)
Pension
Defined Benefit Plan Disclosure [Line Items]
Multiemployer Plan, Employer Contribution, Cost (Credit)	$ 2
Nonpension postretirement
Defined Benefit Plan Disclosure [Line Items]
Multiemployer Plan, Employer Contribution, Cost (Credit)	(9)
Gain (loss) recognized in cost of goods sold \| Pension
Defined Benefit Plan Disclosure [Line Items]
Multiemployer Plan, Employer Contribution, Cost (Credit)	2
Gain (loss) recognized in cost of goods sold \| Nonpension postretirement
Defined Benefit Plan Disclosure [Line Items]
Multiemployer Plan, Employer Contribution, Cost (Credit)	1
Gain (loss) recognized in other income (expense), net \| Pension
Defined Benefit Plan Disclosure [Line Items]
Multiemployer Plan, Employer Contribution, Cost (Credit)	0
Gain (loss) recognized in other income (expense), net \| Nonpension postretirement
Defined Benefit Plan Disclosure [Line Items]
Multiemployer Plan, Employer Contribution, Cost (Credit)	$ (10)

Operating leases (Details) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Lessee, Lease, Description [Line Items]
Operating lease, liability, current	$ 10	$ 6
Building
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	34
Operating lease, liability	34
Operating lease, liability, current	$ 3
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities
Operating lease liabilities, noncurrent	$ 31

Income taxes - (Details)	3 Months Ended
Income taxes - (Details)	Mar. 30, 2024	Apr. 01, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	25.90%	24.30%

Derivative instruments (Details) - USD ($) $ in Millions	3 Months Ended
Derivative instruments (Details) - USD ($) $ in Millions	Mar. 30, 2024	Apr. 01, 2023
Commodity Contracts \| Gain (loss) recognized in cost of goods sold
Derivatives, Fair Value [Line Items]
Gain (loss) recognized in income	$ 0	$ (6)
Commodity Contracts \| Gain (loss) recognized in other income (expense), net
Derivatives, Fair Value [Line Items]
Gain (loss) recognized in income	0	0
Foreign Currency derivatives \| Gain (loss) recognized in cost of goods sold
Derivatives, Fair Value [Line Items]
Gain (loss) recognized in income	0	2
Foreign Currency derivatives \| Gain (loss) recognized in other income (expense), net
Derivatives, Fair Value [Line Items]
Gain (loss) recognized in income	$ 0	$ 0

Supplemental financial statement data - (Details) - USD ($) $ in Millions	Mar. 30, 2024	Dec. 30, 2023
Condensed Financial Statements, Captions [Line Items]
Trade receivables	$ 223	$ 225
Allowance for expected credit losses	0	0
Other receivables	21	19
Accounts receivable, net	244	244
Raw materials	47	49
Manufacturing supplies	53	53
Materials in process	20	15
Finished goods	208	228
Inventories	328	345
Property, cost	2,637	2,676
Accumulated depreciation	(1,902)	(1,937)
Property, net	735	739
Accounts payable	544	541
Obligations under Transition Services Agreement	17	52
Operating lease obligations	10	6
Income taxes payable	12	7
Other	51	40
Other current liabilities	90	105
Other Counterparty
Condensed Financial Statements, Captions [Line Items]
Accounts payable	537	502
Kellanova
Condensed Financial Statements, Captions [Line Items]
Accounts payable	$ 7	$ 39

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

KLG WK Kellogg Co

WK Kellogg Co News

Your Recent History

Company

Business

Popular

Get The App